Latest Funding Risk News

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

Core Lithium has successfully raised A$120 million through a two-tranche institutional placement, securing full funding to restart its Finniss Lithium Operation and target production by Q3 2026.

Stavely Minerals has announced a major upgrade to its Mineral Resource Estimate at the Stavely Copper-Gold Project, more than doubling tonnage and significantly boosting contained metals. This sets a robust foundation for its 2026 Scoping Study targeting a decade-long copper production.

African Gold Ltd has proposed a scheme of arrangement for Montage Gold Corp to acquire 100% of its shares, with an independent expert endorsing the deal as fair and reasonable. The African Gold board unanimously recommends shareholder approval, setting the stage for a significant consolidation in Côte d'Ivoire’s gold sector.

Pilot Energy has locked in a $25 million equity subscription facility with US-based LDA Capital, aiming to fast-track its carbon storage and data centre projects while reducing funding risks.

Riversgold has dramatically expanded its Kalgoorlie Gold Project tenements by over 800%, positioning itself for long-term development with a new mining agreement that shares funding and profits with MEGA Resources.

Global Health Limited reports a modest half-year loss reduction alongside a steady rise in recurring SaaS revenue, signaling progress in its digital healthcare transformation.

Recharge Metals Limited has launched a pro-rata entitlement issue to raise $2.06 million, alongside a $3.97 million placement and a strategic acquisition of the Sunset Well Project in Western Australia. The capital raising aims to fund exploration and working capital, but shareholders face significant dilution and funding risks.

Pioneer Credit has reported a robust first half for FY26, more than doubling its net profit and upgrading its full-year earnings guidance to at least $20 million.

Commonwealth Bank of Australia’s latest Basel III Pillar 3 disclosures reveal steady capital adequacy ratios and proactive adaptation to evolving regulatory standards as of December 2025.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.